Vaccines is the only place in Pfizer where you can contribute to patients in a way like no other – you can prevent sickness and disease. This is at the heart of what drive us every day and it brings us great #Joy. This role will be accountable to shape and drive the strategy for providing protection against Lyme disease in the US. Lyme disease is a systemic infection caused by Borrelia burgdorferi bacteria transmitted to humans by the bite of infected Ixodes ticks. It is considered the most common vector-borne illness in the Northern Hemisphere. Early symptoms of Lyme disease (such as a gradually expanding erythematous rash called erythema migrans or other nonspecific symptoms like fatigue, fever, headache, mild stiff neck, muscle and joint pains) are often overlooked or misinterpreted. Left untreated, the disease can disseminate and cause more serious chronic complications affecting the skin, joints (arthritis), heart (carditis) or nervous system. Preventive measures for Lyme disease are limited by their effectiveness and compliance (e.g., insect repellent, removing ticks promptly and reducing tick habitat) and no vaccine is currently available. The medical need for vaccination against Lyme disease is steadily increasing as the geographic footprint of the disease widens. LB6V (formerly known as VLA-15) is currently undergoing Phase 3 development for the prevention of Lyme Disease in individuals 5 years of age and older. With expected FDA approval in 1H 2027, a US marketing team for LB6V is being formed to advance key pre-launch workstreams. Reporting to the Senior Director, US Lyme Brand Lead, the US Lyme Market Shaping Lead will play a critical leadership role in developing and communicating value propositions for Lyme prevention to a broad range of decision makers across channels and lead strategic planning, key partnerships and initiatives in close partnership with a cross-functional, GLocal team. The Director, Lyme Market Shaping Lead will play a critical role and be accountable for building the strategy and implementation of market development priorities to positively affect market dynamics, set-up the foundation for introduction of LB6V to enable vaccine uptake in high incidence areas. This role is designed to establish strategy for and be implemented based on patient demand, physician willingness and ability to vaccinate, and payer reimbursement to provide full protection against Lyme Disease. The successful candidate will have a demonstrated track record of understanding vaccine market dynamics and key customer insights, developing innovative partnership initiatives with key stakeholders, thriving in complexity and ambiguity, and engaging with a complex and critical set of stakeholders.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director